SPRY - Bathi resik saben saham (EPS TTM) ARS Pharmaceuticals Inc
The growth foundation of ARS Pharmaceuticals (SPRY) is based on the creation of Neffy, the first painless alternative to injections for anaphylaxis. This rolling annual EPS chart confirms this potential, where -2.00 represents the current level of the metric. This breakthrough in emergency medicine is complemented by a stable staff of scientists and targeted reinforcement of the commercial division, ensuring confident business development.
Ringkesan rincian data analitis ARS Pharmaceuticals Inc (SPRY)
- rega saham lan prakiraan rega para ahli:
- statistik kapitalisasi pasar:
- rincian valuasi buku bisnis:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal ARS Pharmaceuticals|SPRY - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas ARS Pharma|SPRY - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku ARS Pharmaceuticals, Inc.|SPRY - Gunggunge utang jangka dawa|Kewajiban jangka cendhak perusahaan ARS Pharmaceuticals|Likuiditas cepet ars-pharma.com
- indikator pendapatan resik lan kelipatan nilai:
SPRY - Bathi sawise pajeg|Proyeksi bathi mangsa ngarep ARS Pharmaceuticals|SPRY - Nilai perusahaan marang bathi resik|Pangali Forward P/E ARS Pharmaceuticals, Inc.|SPRY - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ARS Pharmaceuticals, Inc.|SPRY - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan ARS Pharmaceuticals|SPRY - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ars-pharma.com|SPRY - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep ARS Pharmaceuticals
Analisis umum perusahaan:SPRY - ARS Pharmaceuticals
This indicator measures the company's aggregate net income distributed per common share over the last four quarters, allowing for an assessment of actual profit generation efficiency. For ARS Pharmaceuticals (SPRY), the rolling year net income per share trend verifies the commercial success of the neffy spray, confirming the transition from development to revenue scaling and the strengthening of market positions.
Pesaing ARS Pharmaceuticals
HLN: Bathi resik saben saham sajrone 12 wulan pungkasan|kenvue.com - Bathi saben saham sajrone patang kuartal pungkasan|VRNA: Bathi resik saben saham (EPS TTM)|Jyong Biotech Limited - Bathi saben saham sajroning taun lumaku|LGND (Ligand Pharma) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Amneal Corp AMRX|Bathi saben saham sajrone rolas wulan pungkasan Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) LQDA (Liquidia)|Bathi resik saben saham (EPS TTM) Galapagos N.V. GLPG|ANIP - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajroning taun lumaku MNKD (Afrezza)|Amphastar Pharmaceuticals (AMPH) - Bathi saben saham sajrone rolas wulan pungkasan|PCRX - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham sajrone 12 wulan pungkasan TBPH|AQST: Bathi saben saham sajroning taun lumaku|Bathi saben saham sajrone rolas wulan pungkasan scPharmaceuticals Inc. (SCPH)|TECX: Bathi saben siji saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) TNXP (Tonix Pharmaceuticals)|Bathi saben saham sajroning taun lumaku SXTC|Eupraxia Pharma - Bathi resik saben saham (EPS TTM)|BHST - Bathi resik saben saham (EPS TTM)|Invizyne Technologies, Inc. (EXOZ) - Bathi saben saham sajrone rolas wulan pungkasan|Oramed Pharmaceuticals Inc. - Bathi saben saham sajroning taun lumaku|Bathi saben saham sajrone rolas wulan pungkasan Entera Bio Ltd|Bathi resik saben saham sajrone 12 wulan pungkasan ipatherapeutics.com (HYFT)|Bathi resik saben saham (EPS TTM) ABVC|Bathi resik saben saham (EPS TTM) Cumberland Pharmaceuticals Inc (CPIX)|Bathi resik saben saham (EPS TTM) QNTM (Quantum BioPharma Limited)|FGEN - Bathi resik saben saham sajrone 12 wulan pungkasan|Telomir Pharmaceuticals - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Rani Therapeutics|SNYR (synergychc.com) - Bathi resik saben saham sajrone 12 wulan pungkasan|Rallybio (RLYB) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan LEXX|PULM (Pulmatrix Corporation) - Bathi saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham (EPS TTM) PTHL|Bathi resik saben saham sajrone patang kuartal pungkasan aptorumgroup.com|Bathi resik saben saham (EPS TTM) LYRA (Lyra Therapeutics)|IBO - Bathi resik saben saham sajrone 12 wulan pungkasan|TNF Pharma - Bathi resik saben saham (EPS TTM)|YCBD - Bathi resik saben saham (EPS TTM)|PainReform Ltd. (PRFX) - Bathi saben saham sajrone rolas wulan pungkasan|CYTO (Altamira Therapeutics Ltd.) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Lipella Pharmaceuticals, Inc.|OptiNose Inc (OPTN) - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Pieris (PIRS)|Bathi resik saben saham sajrone patang kuartal pungkasan Procaps Group Corp|Bathi saben saham sajrone rolas wulan pungkasan Petros Pharmaceuticals PTPI|QLI (qlsyy.net) - Bathi saben siji saham sajrone 12 wulan pungkasan|SLRN - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajroning taun lumaku TFFP (TFF Pharmaceuticals Inc.)
